FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Alimera Sciences's Free Cash Flow for the
three
months ended in Dec. 2023 was $3.69 Mil. Alimera Sciences's Revenue for the
three
months ended in Dec. 2023 was $26.31 Mil. Therefore, Alimera Sciences's FCF Margin % for the quarter that ended in Dec. 2023 was 14.01%.
As of today, Alimera Sciences's current FCF Yield % is -47.91%.
The historical rank and industry rank for Alimera Sciences's FCF Margin % or its related term are showing as below:
ALIM'
s FCF Margin % Range Over the Past 10 Years
Min: -595.31 Med: -30.84 Max: -5.54
Current: -111.19
During the past 13 years, the highest FCF Margin % of Alimera Sciences was -5.54%. The lowest was -595.31%. And the median was -30.84%.
ALIM's FCF Margin % is ranked worse than 89.66% of 1025
companies
in the Drug Manufacturers industry
Industry Median: -0.55
vs ALIM: -111.19
Alimera Sciences FCF Margin % Historical Data
The historical data trend for Alimera Sciences's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Alimera Sciences Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
FCF Margin %
-8.02
-5.54
-6.51
-18.90
-111.19
Alimera Sciences Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
FCF Margin %
-2.39
-16.37
-464.31
-42.07
14.01
Competitive Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Alimera Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alimera Sciences FCF Margin % Distribution
For the Drug Manufacturers industry and Healthcare sector, Alimera Sciences's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Alimera Sciences's FCF Margin % falls into.
Alimera Sciences FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Alimera Sciences's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alimera Sciences FCF Margin % Related Terms
Thank you for viewing the detailed overview of Alimera Sciences's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Alimera Sciences (Alimera Sciences) Business Description
Alimera Sciences Inc is a commercial-stage pharmaceutical company developing and commercializing ILUVIEN for the treatment of diabetic macular edema (DME), a leading cause of blindness, and outside the U.S. for non-infectious uveitis affecting the posterior segment of the eye (NIU-PS). ILUVIEN is a sustained-release intravitreal implant that enables patients to maintain vision longer, and importantly, with fewer injections. The company commercializes ILUVIEN in the U.S., Europe, China and the Middle East.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ALIM has been successfully added to your 